This division of AAM educates patients about the safety and effectiveness of biosimilars, according to a May 24 release. Member organizations include manufacturers developing biosimilar products for the U.S. market.
In his role at ASCA, Mr. Selde represented ASCs before both federal agencies and Congress.
Mr. Selde attended Creighton University School of Law in Omaha, Neb., and received his BA from New York City-based Fordham University.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.